CXCR4 and Familial prostate cancer: In addtion, prostate cancer progenitor cells express CXCR4 [27] and often these cells are resistant to current chemo and radiation therapy practices, thus, combination therapy with anti-CXCR4 strategies consisting of CTCE-9908 may prevent the further spread of tumor in patients.